rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2005-7-25
|
pubmed:abstractText |
To compare the safety and intraocular pressure (IOP)-lowering efficacy of travoprost 0.004%/timolol 0.5% fixed combination ophthalmic solution (Trav/Tim) to its components travoprost 0.004% ophthalmic solution, TRAVATAN, (Trav) and timolol 0.5% ophthalmic solution (Tim) in patients with open-angle glaucoma or ocular hypertension.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0002-9394
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
140
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1-7
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15990081-Adult,
pubmed-meshheading:15990081-Aged,
pubmed-meshheading:15990081-Aged, 80 and over,
pubmed-meshheading:15990081-Antihypertensive Agents,
pubmed-meshheading:15990081-Blood Pressure,
pubmed-meshheading:15990081-Cloprostenol,
pubmed-meshheading:15990081-Double-Blind Method,
pubmed-meshheading:15990081-Drug Combinations,
pubmed-meshheading:15990081-Female,
pubmed-meshheading:15990081-Glaucoma, Open-Angle,
pubmed-meshheading:15990081-Heart Rate,
pubmed-meshheading:15990081-Humans,
pubmed-meshheading:15990081-Intraocular Pressure,
pubmed-meshheading:15990081-Male,
pubmed-meshheading:15990081-Middle Aged,
pubmed-meshheading:15990081-Ocular Hypertension,
pubmed-meshheading:15990081-Ophthalmic Solutions,
pubmed-meshheading:15990081-Safety,
pubmed-meshheading:15990081-Timolol,
pubmed-meshheading:15990081-Treatment Outcome
|
pubmed:year |
2005
|
pubmed:articleTitle |
The safety and efficacy of travoprost 0.004%/timolol 0.5% fixed combination ophthalmic solution.
|
pubmed:affiliation |
University of Washington, Ophthalmology, Specialty Eye Care Center, Seattle, 98004, USA. h.barnebey@verizon.net
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|